| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.031 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |